Latest equities thinking

Issuance, support from equities and volatility: The outlook for convertible bonds in 2021

18 Dec 2020

Shawn Mato, convertible bond fund manager, picks three themes that could have a big say in how the asset class performs in 2021.

Read more

Recovery, divergence and externalities: The outlook for global equities in 2021

15 Dec 2020

Giles Parkinson, global equities portfolio manager at Aviva Investors, looks at three themes that will shape the asset class in 2021.

Read more

Reversal of fortunes, Brexit and dividends: The outlook for UK equities in 2021

11 Dec 2020

Trevor Green, UK equity portfolio manager at Aviva Investors, picks three themes that could have a big say in how the asset class performs in 2021.

Read more

Selectivity, sanctions and decarbonisation: The outlook for emerging market equities in 2021

11 Dec 2020

Alistair Way, head of emerging market equities at Aviva Investors, looks at three themes that will shape the asset class in 2021.

Read more

COVID, climate and Black Lives Matter: The stories that defined 2020

10 Dec 2020

We select some of our key pieces of content in a year of unending drama.

Read more

Chemical compounds: The good, the bad and the ugly

9 Dec 2020

After decades of secrecy, light is increasingly being shone on the potentially hazardous compounds produced by chemical companies. In the latest instalment of our editorial series, Link, experts from Aviva Investors’ credit, equities and ESG teams discuss the prevalence of chemicals in modern life, and how to balance usefulness and safety.

Read more

Pricing power is the magic ingredient for equity investors

27 Nov 2020

Evidence that a company wields pricing power in its industry is the best indication of a sustainable competitive advantage, argues Giles Parkinson.

Read more

Once bitten, twice shy: Is there value in tech by avoiding the FAANGs?

30 Oct 2020

The gravity-defying rally in technology shares has led some commentators to draw comparisons with the bubble of the late 1990s. However, Mikhail Zverev and Alistair Way believe there are still opportunities to be found in some of the sector’s less-fashionable stocks.

Read more

US Election 2020: Expect the unexpected

29 Oct 2020

As the US presidential election looms, we explore potential scenarios – from a Democratic “blue sweep” to a Trump re-election to a divided government – and assess the implications for investors.

Read more

Turn and face the change: How to invest dynamically in an uncertain world

21 Oct 2020

Equity markets are slow to price in the implications of change. This creates opportunities for dynamic, style-agnostic investors to take advantage, argue Caroline Galligan and David Cumming.

Read more

Don’t feed the troll: Social media companies face reckoning over hate speech

28 Sep 2020

Facebook, Twitter and other platforms are drawing criticism for their failure to tackle hate content. But will the hit to their reputation do any lasting commercial damage?

Read more

Investing in the gut: Fixing the bacterial bugs in our microbiome

21 Sep 2020

COVID-19 has intensified interest in the human microbiome, as researchers contemplate whether bacteria living in the gut might affect susceptibility to infection. Drawing on our experience in public markets and Ahren Innovation Capital’s knowledge of private markets, we look at the companies making strides in live biotherapeutics, using ‘bugs as drugs’, and key challenges that need to be overcome.

Read more

AIQ Investment Thinking

Get our perspective on key themes influencing investment markets globally.
Read more

House View

A quarterly publication which encapsulates the thinking of our investment team.

Read more